Full Fed. Circ. Won't Reconsider Bio-Rad's $24M IP Verdict
The full Federal Circuit on Wednesday refused to revisit a decision that 10X Genomics should pay Bio-Rad and the University of Chicago $24 million for infringing a DNA manipulation patent, unmoved...To view the full article, register now.
Already a subscriber? Click here to view full article